These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 458614)

  • 21. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 22. Mescaline: the chemistry and pharmacology of its analogs.
    Shulgin AT
    Lloydia; 1973 Mar; 36(1):46-58. PubMed ID: 4576313
    [No Abstract]   [Full Text] [Related]  

  • 23. SYNTHESIS OF PHENETHYLAMINES RELATED TO MESCALINE AS POSSIBLE PSYCHOTOMIMETIC AGENTS.
    FRIEDMAN OM; PARAMESWARAN KN; BURSTEIN S
    J Med Chem; 1963 May; 6():227-9. PubMed ID: 14185972
    [No Abstract]   [Full Text] [Related]  

  • 24. Stimulation of human prolactin secretion by mescaline.
    Demisch L; Neubauer M
    Psychopharmacology (Berl); 1979 Sep; 64(3):361-3. PubMed ID: 116281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
    Snyder SH; Faillace L; Hollister L
    Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformationally constrained analogs of mescaline.
    Wolters RJ; Bej AJ; Tanner NS
    J Pharm Sci; 1974 Sep; 63(9):1379-82. PubMed ID: 4427260
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients.
    Barfknecht CF; Nichols DE
    J Med Chem; 1975 Feb; 18(2):208-10. PubMed ID: 1120990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues.
    Nichols DE; Dyer DC
    J Med Chem; 1977 Feb; 20(2):299-301. PubMed ID: 836502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA.
    KEELER MH
    N C Med J; 1963 Dec; 24():555-7. PubMed ID: 14089896
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies on mescaline: the effect of dimethoxyphenylethylamine and N:N-dimethyl mescaline on the conditioned avoidance response in the rat.
    Smythies JR; Sykes EA
    Psychopharmacologia; 1966; 8(5):324-30. PubMed ID: 5923938
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of mescaline and 2,5-dimethoxy-4-methylphenethylamine on sleeping time in mice.
    Ho BT; Huang JT
    J Pharm Pharmacol; 1970 Dec; 22(12):949-51. PubMed ID: 4395524
    [No Abstract]   [Full Text] [Related]  

  • 34. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
    J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An economical screen for phenethylamine-type hallucinogens: mouse ear scratching.
    Yim GK; Prah TE; Pfister WR; Nichols DE
    Commun Psychopharmacol; 1979; 3(3):173-8. PubMed ID: 574070
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 38. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of psychotomimetic effect of para-methoxyphenylethylamine and 3,4-dimethoxyphenethylamine in man.
    Brown WT; McGeer PL; Moser I
    Can Psychiatr Assoc J; 1968 Feb; 13(1):91-2. PubMed ID: 5644428
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: The activation of pineal hydroxyindole-O-methyltransferase by psychotomimetic drugs.
    Hartley R; Smith JA
    J Pharm Pharmacol; 1973 Sep; 25(9):751-2. PubMed ID: 4148515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.